Skip to main content

Table 1 The collection of 14 known host resistance genes

From: Prioritizing genes responsible for host resistance to influenza using network approaches

Entrez ID

Gene symbol

Gene description

Mouse ortholog

Cytoband

Supporting evidence

4599

MX1

myxovirus (influenza virus) resistance 1

Mx1, Mx2

21q22.3

Mouse strains homozygous for Mx null allele fail to synthesize Mx protein and are influenza virus susceptible[22].

9437

NCR1

natural cytotoxicity triggering receptor 1

Ncr1

19q13.42

Ncr1-/- 129/Sv and C57BL/6 mice were lethal after influenza virus infection[23].

1234

CCR5

chemokine (C-C motif) receptor 5

Ccr5

3p21.31

Deaths among Ccr5-/- mice increase after infection with influenza A virus[22]. A large proportion of heterozygosity for the CCR5Δ 32 allele among white patients with severe disease was also found[24].

114548

NLRP3

NLR family, pyrin domain containing 3

Nlrp3

1q44

Mice lacking Nlrp3 exhibited dramatically increased mortality and a reduced immune response after exposure to the influenza virus[25]. Gene polymorphisms in the NALP3 inflammasome are associated with interleukin-1 production and severe inflammation in human[26].

3105

HLA-A

major histocompatibility complex, class I, A

H2-D1

6p21.3

The magnitude and specificity of influenza A virus-specific cytotoxic T-lymphocyte responses in humans is associated with the HLA-A and -B phenotypes[27].

3106

HLA-B

major histocompatibility complex, class I, B

2212

FCGR2A

Fc fragment of IgG, low affinity IIa, receptor (CD32)

Fcgr3

1q23

rs1801274 on FCGR2A is significantly (p < 0.0001, OR = 2.68, 95% CI: 1.69-4.25) associated with sever pneumonia after A/H1N1 infection in human[28].

84268

RPAIN

RPA interacting protein

Rpain

17p13.2

rs8070740 on RPAIN is significantly (p < 0.0001, OR = 2.67, 95% CI: 1.63-4.39) associated with sever pneumonia after A/H1N1 infection in human[28].

3456

IFNB1

interferon, beta 1, fibroblast

Ifnb1

9p21

IFN-β-deficient mice carrying functional Mx1 alleles showed 20-fold lower in the 50% lethal dose of H7N7; and also substantially reduced resistance to H1N1 infection[29].

3586

IL10

interleukin 10

Il10

1q31-q32

A promoter polymorphism conferred a significantly decreased risk of adverse response to inactivated influenza vaccine[30].

708

C1QBP

complement component 1, q subcomponent binding protein

C1qbp

17p13.3

rs3786054 on C1QBP is significantly (p < 0.0001, OR = 3.13, 95% CI: 1.89-5.17 ) associated with sever pneumonia after A/H1N1 infection in human[28].

3811

KIR3DL1

killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1

Kir3dl1

19q13.4

KIR3DL1/S1 and 2DL1 ligand-negative pairs were enriched among H1N1 ICU cases[31].

3803

KIR2DL2

killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 2

Kir3dl2

19q13.4

KIR2DL2/L3 ligand-positive pairs were enriched among H1N1 ICU cases[31].

10410

IFITM3

interferon induced transmembrane protein 3

Ifitm3

11p15.5

Mice lacking Ifitm3 display fulminant viral pneumonia when challenged with a normally low-pathogenicity influenza virus. A statistically significant number of hospitalized subjects were also shown enrichment for a minor IFITM3 allele that alters a splice acceptor site[32].